As environmental issues become ever more pressing, pharmaceutical giant Boehringer Ingelheim is leading a green revolution within its industry, with a special focus on sustainable vaccine production. The company's innovative initiatives extend well beyond the finished vaccine. Boehringer
Upstream bioprocessing is pivotal in biomanufacturing, where cellular systems produce vital therapeutic proteins and biological products. This field is experiencing a surge of innovative methods in response to the increased global demand for biopharmaceuticals driven by rising health concerns.
How Is Tech Innovation Shaping Biopharma Production? The biopharmaceutical industry is experiencing profound change thanks to technological advancements. These innovations are not just fine-tuning existing methods; they're revolutionizing drug development and production. Advanced analytics and
The fusion of synthetic biology (SynBio) with architecture is marking the beginning of a revolutionary shift towards eco-friendly building methods. At the forefront is Ginger Dosier with her pioneering company, Biomason; she represents the future of green construction. SynBio's integration
Managing conditions in a bioreactor is critical for successful bioprocessing. This is especially so when dealing with fragile cultures such as CHO cells, where pH levels are crucial for encouraging growth and production. Traditional electrochemical probes have been favored for monitoring pH due to
In a groundbreaking clinical trial, an innovative cardiac bioimplant named PeriCord has shown signs of fostering heart tissue repair following a myocardial infarction. Developed by the ICREC at the Germans Trias i Pujol Research Institute and the Banc de Sang i Teixits in Barcelona, Spain, PeriCord
